HDFC Manufacturing Fund vs SBI Healthcare Opportunities Fund
Portfolio Overlap Analysis · HDFC vs SBI
11.8%
Low Overlap
7 common stocks · Rank #18267 of 28,292 pairs
Common Holdings (7)
| Stock | Wt% in HDFC Manufacturing | Wt% in SBI Healthcare Opportunities | Overlap |
|---|---|---|---|
Divi's Laboratories Ltd. Pharmaceuticals & Biotechnology | 7.55% | 4.24% | 4.24% |
Sun Pharmaceutical Industries Ltd. Pharmaceuticals & Biotechnology | 10.65% | 2.30% | 2.30% |
Lupin Ltd. Pharmaceuticals & Biotechnology | 4.23% | 1.91% | 1.91% |
Gland Pharma Ltd. Pharmaceuticals & Biotechnology | 2.68% | 1.55% | 1.55% |
Anthem Biosciences Ltd. Pharmaceuticals & Biotechnology | 2.68% | 1.02% | 1.02% |
Sudeep Pharma Ltd. Pharmaceuticals & Biotechnology | 2.13% | 0.53% | 0.53% |
Cohance Lifesciences Ltd. Pharmaceuticals & Biotechnology | 0.91% | 0.26% | 0.26% |
Unique to HDFC Manufacturing
- Reliance Industries Ltd.5.56%
- Maruti Suzuki India Limited4.24%
- JSW Steel Ltd.3.66%
- Tata Motors Limited3.30%
- Mahindra & Mahindra Ltd.3.27%
- Bharat Electronics Ltd.2.73%
- Tata Motors Passenger Vehicles Limited2.60%
- Bajaj Auto Limited2.50%
- Bharat Forge Ltd.2.35%
Unique to SBI Healthcare Opportunities
- Apollo Hospitals Enterprise Ltd.5.76%
- Max Healthcare Institute Ltd.4.82%
- Acutaas Chemicals Ltd.4.77%
- Torrent Pharmaceuticals Ltd.4.25%
- Aster DM Healthcare Ltd.3.85%
- Biocon Ltd.3.59%
- Laurus Labs Ltd.3.48%
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology11.8% (7)
Analysis
AI-generated comparative analysis coming soon.
More comparisons for HDFC Manufacturing
- vs MZ49.0% · 31 stocks
- vs Nippon India Nifty India Manuf49.0% · 31 stocks
- vs ICICI Prudential Manufacturing35.4% · 34 stocks
- vs HDFC Innovation31.0% · 22 stocks
- vs NIPPON INDIA QUANT23.7% · 10 stocks
More comparisons for SBI Healthcare Opportunities
- vs HDFC Pharma and Healthcare54.8% · 16 stocks
- vs HEALETF53.4% · 12 stocks
- vs NIPPON INDIA PHARMA48.6% · 19 stocks
- vs ICICI Prudential Nifty Pharma 44.1% · 11 stocks
- vs NH44.1% · 11 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.